Hypoxia and anaemia in head and neck squamous cell carcinoma - mechanisms of therapy failure and provision of new therapeutic targets

This publication has 20 references indexed in Scilit:

• Targeting HIF-1 for cancer therapy
  Nature Reviews Cancer, 2003
• Overexpression of hypoxia-inducible-factor 1α(HIF-1α) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage
  British Journal of Cancer, 2003
• Significant correlation of hypoxia-inducible factor-1α with treatment outcome in cervical cancer treated with radical radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Regulation of angiogenesis by hypoxia: role of the HIF system
  Nature Medicine, 2003
• Hypoxia — a key regulatory factor in tumour growth
  Nature Reviews Cancer, 2002
• Hypoxia as a target for combined modality treatments
  European Journal Of Cancer, 2002
• Activation of the HIF pathway in cancer
  Current Opinion in Genetics & Development, 2001
• Impact of Anemia in Patients With Head and Neck Cancer
  The Oncologist, 2000
• Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell Lines
  Journal of Biological Chemistry, 1999
• Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
  Proceedings of the National Academy of Sciences, 1997